| After the University of Louisiana at Lafayette played a key role in the development of a COVID-19 vaccine in 2020, its New Iberia Research Center is poised for an upgrade that would allow the center to take a drug through research, testing and manufacturing. Read more |
|
|
|
|
|
|
---|
Copyright © 2022 theadvocate.com. All Rights Reserved |
|
|
|
---|
|
|